Connect with us

Company News

AHH announces key leadership changes

Asia Healthcare Holdings leadership recently announced significant executive appointments to strengthen its specialty healthcare platform. Firstly, the Bengaluru-based organization named Venkatesh Tarakkad as the new Chief Financial Officer and head of business development. Consequently, this strategic move signals a new phase of operational expansion for the GIC-TPG backed entity. Tarakkad brings over thirty years of experience in corporate finance and governance to the role.

Venkatesh Tarakkad: New financial head
Venkatesh Tarakkad joins the group from the edtech unicorn UpGrad, where he managed domestic and international financial operations. In his new capacity, he will oversee finance across all AHH group companies. Additionally, he will lead corporate functions including legal, internal audit, and business development. Previously, Tarakkad held leadership roles at Ecom Express and TCNS Clothing. Therefore, his expertise in IPO processes and funding rounds will be invaluable for the platform’s growth agenda.

Strategic shift in Asia Healthcare Holdings leadership
In a related development, Ritesh Pandey has transitioned to the role of Chief Business Officer for new initiatives. Since joining AHH in 2019, Pandey has served as a cornerstone of the organization’s finance function. He will now focus specifically on strategic partnerships and the development of new business verticals. Furthermore, his previous success in executing pivotal M&A transactions has defined the growth of the enterprise. This internal elevation allows the platform to leverage his experience for future scaling efforts.

Expanding the specialty healthcare network
The company continues to operate a robust network of specialty brands across India. Currently, the AHH portfolio includes prominent names such as Motherhood Hospitals and Nova IVF Fertility. It also manages the Asian Institute of Nephrology and Urology. Because the demand for specialty care is rising, these leadership changes remain vital for maintaining clinical excellence. Notably, the group remains backed by global asset managers GIC and TPG. These appointments ensure the platform is well-positioned to meet its long-term objectives. OC Academy

Copyright © 2026 Medical Buyer maintained by Algocept

error: Content is protected !!